| 646778 |
NANOMATERIALS |
Nanocomposites for Environmental and Energy Applications |
2021-01-31 |
10.3390/nano11020345 |
Goh Pei Sean, Ismail Ahmad Fauzi |
| 646777 |
ADVANCED PHARMACEUTICAL BULLETIN |
CEP55 Inhibitor: Extensive Computational Approach Defining a New Target of Cell Cycle Machinery Agent |
2021-01-31 |
10.34172/apb.2022.021 |
Lestari Beni, Utomo Rohmad Yudi |
| 646776 |
BMB REPORTS |
The role of dendritic cells in tumor microenvironments and their uses as therapeutic targets |
2021-01-31 |
10.5483/bmbrep.2021.54.1.224 |
Kim, Chae Won, Kim, Kyun-Do, Lee, Heung Kyu |
| 646775 |
BMB REPORTS |
Update of early phase clinical trials in cancer immunotherapy |
2021-01-31 |
10.5483/bmbrep.2021.54.1.242 |
Lee, Dae Ho |
| 646774 |
CURĒUS : MEDICAL KNOWLEDGE FOR THE WORLD |
A Rare Presentation of Isolated Right Colon Ischemia: The Mass-Forming Variant |
2021-01-31 |
10.7759/cureus.13028 |
Turki M'hamed, Chakraborti Anumita, Bella Saif, Hila Amine, Timsar Ali |
| 646773 |
CANCERS |
Hepatitis B Virus Covalently Closed Circular DNA Predicts Postoperative Liver Cancer Metastasis Independent of Virological Suppression |
2021-01-31 |
10.3390/cancers13030538 |
Hsu Chao-Wei, Chu Yu-De, Lai Ming-Wei, Lin Chih-Lang, Liang Kung-Hao, Lin Yang-Hsiang, Yeh Chau-Ting |
| 646772 |
ADVANCED PHARMACEUTICAL BULLETIN |
Recombinant Expression and Biophysical Characterization of a Druggable Schistosoma mansoni Universal Stress G4LZI3 Protein |
2021-01-31 |
10.34172/apb.2022.035 |
Adenowo Abiola Fatimah, Masamba Priscilla, Qokoyi Ndibonani Kebonang, Oyinloye Babatunji Emmanuel, Kappo Abidemi Paul |
| 646771 |
CELLS |
PARP1 as a Marker of an Aggressive Clinical Phenotype in Cutaneous Melanoma—A Clinical and an In Vitro Study |
2021-01-31 |
10.3390/cells10020286 |
Kupczyk Piotr, Simiczyjew Aleksandra, Marczuk Jakub, Dratkiewicz Ewelina, Beberok Artur, Rok Jakub, Pieniazek Malgorzata, Biecek Przemyslaw, Nevozhay Dmitry, Slowikowski Bartosz, Chodaczek Grzegorz, Wrzesniok Dorota, Nowak Dorota, Donizy Piotr |
| 646770 |
ADVANCED PHARMACEUTICAL BULLETIN |
Exendin-4 as a Versatile Therapeutic Agent for the Amelioration of Diabetic Changes |
2021-01-31 |
10.34172/apb.2022.025 |
Rajabi Hadi, Ahmadi Mahdi, Aslani Somayeh, Saberianpour Shirin, Rahbarghazi Reza |
| 646769 |
CELLS |
The Prognostic Values of PARP-1 Expression in Uveal Melanoma |
2021-01-31 |
10.3390/cells10020285 |
Gajdzis Malgorzata, Theocharis Stamatios, Klijanienko Jerzy, Cassoux Nathalie, Gardrat Sophie, Donizy Piotr, Kaczmarek Radoslaw, Gajdzis Pawel |
